4Canney PA,Moore M,Wilkinson PM,et al.Ovarian cancer antigen CA 125:a prospective clinical assessment of its role as tumour marker[J].Br J Cancer,1984,50(6):765~769.
5Haliha H,Stenman UH,Seppala M.Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy [J].Cancer,1986,57(7):1327~1329.
6Zacharos ID,Efstathious SP,Petreli E,et al.The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma [J].Eur J Haematol,2002,69(4):221 ~226.
7Lazzarino M,Orlandi E,Klersy C,et al.Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma:correlation with tumor parameters and disease activity [J].Cancer,1998,82 (3):576 ~ 582.
8Jaffe ES,Harris NL,Stein H,et al.World health orgnization classification of tumours.pathology and genetics of tumours of haematopoietic and lymphoid tissue[M].Lyon:IARC Press,2001.
9Shipp MA.Can we improve upon the International Index[J].Ann Oncol,1997,8 (Suppl 1):43 ~ 47.
2Ojha RP, Brown LM, Felini MJ, et al. Addressing uncer- tainty regarding the utility of carbohydrate antigen-125 as a prognostic marker in non-Hodgkin lymphoma[J]. Leuk Lymphoma, 51 (9) :1754-1757.
3Prochdzka V,Faher E, Raida L,et al. High serum carbo hydrate antigen 125(CA-125) level predicts poor outcome in patients with follicular lymphoma independently of the FLIPI score[J].Int J Hematol, 96 (1) .. 58-64.
4Guti6rrez A, Martlnez-Serra J, Barcel6 B, et al. Prognostic value of serum CA125 levels in diffuse large B-cell lym- phoma., potential role of a new sex-and age-adjusted refer- ence value[J]. Int J Lab Hematol,2010,32(6 Pt 2) ..582- 589.
5Benboubker L, Valat C, Linassier C,et al. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels[J]. Ann Oncol, 2000,11 ( 11 ) : 1485-1491.